Nothing Special   »   [go: up one dir, main page]

MX9707683A - Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan. - Google Patents

Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan.

Info

Publication number
MX9707683A
MX9707683A MX9707683A MX9707683A MX9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A
Authority
MX
Mexico
Prior art keywords
benazeprilat
valsartan
combination compositions
compositions containing
formula
Prior art date
Application number
MX9707683A
Other languages
English (en)
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX9707683A publication Critical patent/MX9707683A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se refiere a composiciones de combinacion farmacéuticas para el tratamiento de hipertension, insuficiencia cardíaca congestiva, en insuficiencia renal, las cuales comprenden: (1) el inhibidor de enzima convertidora de angiotensina benazepril de la formula (I), o benazeprilat de la formula (II), o una sal farmacéuticamente aceptable de los mismos, y (2) el antagonista de AT1 valsartan de la formula (III) o una sal farmacéuticamente aceptable del mismo, así como a métodos para el tratamiento de hipertension, insuficiencia cardíaca congestiva, e insuficiencia renal.
MX9707683A 1995-04-07 1996-04-02 Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan. MX9707683A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (1)

Publication Number Publication Date
MX9707683A true MX9707683A (es) 1997-12-31

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707683A MX9707683A (es) 1995-04-07 1996-04-02 Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan.

Country Status (15)

Country Link
EP (1) EP0820302A1 (es)
JP (1) JPH11503139A (es)
KR (1) KR19980703647A (es)
CN (1) CN1181019A (es)
AU (1) AU5399096A (es)
BR (1) BR9604818A (es)
CA (1) CA2214143A1 (es)
CZ (1) CZ313897A3 (es)
HU (1) HUP9801593A2 (es)
MX (1) MX9707683A (es)
NO (1) NO974400D0 (es)
PL (1) PL322529A1 (es)
SK (1) SK133897A3 (es)
TR (1) TR199701121T1 (es)
WO (1) WO1996031234A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835106A4 (en) * 1995-06-30 1998-09-30 Merck & Co Inc METHOD FOR TREATING KIDNEY DISEASES USING AN ACE INHIBITOR AND AII ANTAGONIST
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
CA2405793A1 (en) * 2000-04-12 2001-10-18 Novartis Ag Combination of organic compounds
AU2001289672B2 (en) * 2000-07-19 2005-12-08 Novartis Ag Valsartan salts
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
JP2004520268A (ja) * 2000-08-22 2004-07-08 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト アンギオテンシンｉｉ拮抗剤とアンギオテンシンｉ変換酵素阻害剤とを含有する医薬組成物
KR20040007420A (ko) * 2000-12-18 2004-01-24 노파르티스 아게 암로디핀 및 베나제프릴의 치료용 배합물
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN1465712A (zh) * 2002-07-05 2004-01-07 安徽省生物医学研究所 一种预测acei类降压药药效的试剂盒、方法、软件和复方药
JP2006516020A (ja) * 2002-08-28 2006-06-15 キュリス インコーポレイテッド 慢性腎不全の治療におけるモルフォゲン及びａｃｅ阻害薬の共投与
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
US8871795B2 (en) 2009-05-20 2014-10-28 Boehringer Ingleheim Vetmedica Gmbh Pharmaceutical oral telmisartan solution
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
MX2016010011A (es) * 2014-01-31 2016-10-07 Janssen Pharmaceutica Nv Metodos para tratar y prevenir trastornos renales y trastornos del higado graso.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729938B2 (ja) * 1990-05-11 1995-04-05 フアイザー・インコーポレイテツド 相乗的治療用組成物及び方法
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
CN1181019A (zh) 1998-05-06
CA2214143A1 (en) 1996-10-10
HUP9801593A2 (hu) 1999-01-28
AU5399096A (en) 1996-10-23
EP0820302A1 (en) 1998-01-28
CZ313897A3 (cs) 1998-01-14
WO1996031234A1 (en) 1996-10-10
JPH11503139A (ja) 1999-03-23
KR19980703647A (ko) 1998-12-05
NO974400L (no) 1997-09-23
NO974400D0 (no) 1997-09-23
BR9604818A (pt) 1998-06-09
SK133897A3 (en) 1998-02-04
TR199701121T1 (xx) 1998-03-21
PL322529A1 (en) 1998-02-02

Similar Documents

Publication Publication Date Title
MX9707683A (es) Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan.
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
GB9914486D0 (en) Medicaments
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
BG106340A (en) Substituted oxoazaheterocyclyl compounds
BG104177A (en) Amlodipin- and atorvastatin-containing therapeutical combinations
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
HUP9900773A3 (en) Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
BG103947A (en) Derivatives of 9-oxymerythromycin
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
WO1999026932A8 (en) By amidino group substituted heterocyclic derivatives and their use as anticoagulants
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
DE69530123D1 (en) Plättchenaggregationsinhibitoren
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
MY118704A (en) Process for preparation of eprosartan